Milestone Scientific (MLSS) Asset Writedowns and Impairment (2010 - 2026)

Milestone Scientific (MLSS) reported Asset Writedowns and Impairment of $4014.0 for Q1 2026, up 28.9% sequentially from $3114.0 in Q4 2025.

Milestone Scientific (MLSS) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends

Milestone Scientific (MLSS) has 9 years of Asset Writedowns and Impairment data on file, last reported at $4014.0 in Q1 2026.

For the quarter ending Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $4014.0; the trailing twelve-month figure through Mar 2026 stood at $7128.0 (changed N/A YoY), and the FY2025 full-year result was $11639.0, changed N/A from the prior year.
Asset Writedowns and Impairment advanced to $4014.0 in Q1 2026, from $3114.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $8789.0 in Q4 2023 to a low of $3114.0 in Q4 2025.
A 3-year average of $5305.7 and a median of $4014.0 in 2026 frame the typical range for Asset Writedowns and Impairment.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Milestone Scientific	33.00 Mn	31.35 Mn	1.56 Mn

Download Data